Alzheimer's Weekly

Options

» Caregivers
» Fight the Fight
» Items of Interest
» Prevention
» Research
» Treatment
» Weekly Videos

Ads

Enjoy Mediterranean Diet Food. Free shipping on orders over $50

Newsletter

Research

Leukine Rushed to Clinical Trials

A box of Leukine (generic: sargramostim).

VIDEO & IN-DEPTH ARTICLE

An impressive new study suggests Leukine should be tested in humans as a potential treatment for Alzheimer's disease. It is already FDA approved to treat cancer and has a strong safety record.

VIDEO + TRANSCRIPT

The effort to develop a new treatment for Alzheimer's suffered a blow this week, as Ely Lilly halted the Semagacestat clinical trial. PBS asks Dr. Paul Aisen where do we go from here. Dr. Aisen was involved in the early stages of the Eli Lilly trial.

VIDEO + TRANSCRIPT

Watch this brilliant new video from Intellect Neurosciences showing how antisenilin antibodies clear Alzheimer's plaque. See and understand the way clinical-trial vaccines like bapineuzumab fight dementia.

Undergoing a deep brain stimulation operation

VIDEO + RELATED ARTICLE

Alzheimer's patient Robert Linton has been wearing a deep-brain stimulation device for two years. He says he feels the difference. See the video.

Why Education Fights Dementia

Studies consistently show that more time spent in education lowers dementia risk. In this new study, each additional year of education delivers an 11% decrease in risk of developing dementia. Learn why.

MIT biology professor Leonard Guarente (Photo: Donna Coveney)

The SIRT1 gene, producing sirtuin proteins, could control production of Alzheimer's devastating amyloid plaques. Find out how MIT researchers used SIRT1 to improve learning and memory in the lab.

Many Steps Forward at ICAD

Entrance to the International Conference on Alzheimer's Disease (ICAD) at the Honolulu Convention Center

This week, 4,000 scientists from around the world gathered in Honolulu at the Alzheimer's Association's 2010 International Conference on Alzheimer's Disease (ICAD). Browse Alzheimer's Weekly's clickable index of their new insights into dementias such as Alzheimer's.

Experts sit on The NIH Alzheimer's Prevention Panel

Scientists identified a chemical that encourages the growth of neurons (brain cells) integral to learning and memory. P7C3 essentially seems to give "protection" to neurons. It could lead to a new neuroprotective drug.

Bapineuzumab Progress

Dayna Wright in front of a banner that reads, "Life Changing Study"

VIDEO & TRANSCRIPT

"In my mind, this is the single most important clinical study yet done in Alzheimer's," says Dr. D. Winegarner. Bapineuzumab cleans away Alzheimer's plaque. It is undergoing world-wide advanced-stage clinical trials. Learn more about its exciting progress.

The new imaging compound florbetapir promises to settle tricky cases. Since 400 forms of dementia exist, it is challenging to make an accurate diagnosis. Now, florbetapir offers a way to accurately distinguish Alzheimer's from many other types of dementia.